JPRN-UMIN000023854
Recruiting
未知
Efficacy Study of Repeated Doses of L-arginine in Patients with HTLV-1 Associated Myelopathy - Efficacy Study of Repeated Doses of L-arginine in Patients with HTLV-1 Associated Myelopathy
Overview
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients for whom dosage or mode of administration of steroids or other drugs targeting HAM/TSP has been changed within 12 weeks prior to signing the patient informed consent (2\) Patients who have received pulse steroid therapies or doses of interferon within one year prior to signing the patient informed consent (3\) Patients who have participated in interventional studies within 16 weeks prior to signing the patient informed consent (4\) Patients whose result of 10 meters walk test obtained on screening varies by more than 30 percent compared to those obtained within eight weeks prior to signing the patient informed consent, which include any data collected during single or multiple hospital visits (5\) Patients with serious complications such as heart failure, lung diseases, kidney failure, liver failure and uncontrolled diabetes (6\) Patients with cancer or history of cancer Note, however, that patients with solid tumors which were completely removed and have not recurred within three years prior to signing the patient informed consent may be included. Patients with basal cell cancer of skin, squamous cell cancer (except for malignant melanomas), non\-invasive cervical cancer, or cancer in situ of the gastrointestinal tract or corpus uteri, which have been completely cured may also be included even if the patient developed one of those diseases within three years prior to signing the patient informed consent (7\) Patients with ATL (8\) Pregnant or breast\-feeding women, women suspected of being pregnant and patients who do not consent to prevent conception by taking appropriate means with the assistance of their partners during the study period (9\) Patients with compressive spinal cord lesions such as osteoarthritis of the spine, ossification of posterior longitudinal ligament, ossification of yellow ligament, which preclude assessment using the walk tests or can worsen the patients symptoms
Investigators
Similar Trials
Completed
Phase 3
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.Sickle cell disease.Other sickle-cell disorders with crisisD57.81IRCT20170112031891N2Ahvaz University of Medical Sciences120
Active, not recruiting
Phase 1
Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome.EUCTR2005-004639-24-ITOSPEDALE S. RAFFAELE294
Completed
Phase 3
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
Recruiting
Phase 1
Arginine effect on height growth of childreIRCT20230603058376N1Ardabil University of Medical Sciences76
Recruiting
Phase 3
Comparison between L-arginine and aspirin and aspirin alone in preventing preeclampsia in high-risk pregnant women.IRCT20221108056440N1Kashan University of Medical Sciences90